跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEMETREXED FRESENIUS KABI 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PEMETREXED FRESENIUS KABI 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
PEMETREXED FRESENIUS KABI 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Fresenius Kabi Deutschland Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 9, 2020
Approval ID
0f586833c8f8609e
Company
Fresenius Kabi Deutschland Gmbh
Type
Standard
Approval Details
Approval Id
0f586833c8f8609e
Drug Cima Aemps Name
PEMETREXED FRESENIUS KABI 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1161115003
Holder Company Name
Fresenius Kabi Deutschland Gmbh
Marketing Company Name
Fresenius Kabi España, S.A.U.
Holder Company Detail Path
/organization/fresenius-kabi-deutschland-gmbh
Authorization Date
2020-06-09
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
25 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Fresenius Kabi Deutschland Gmbh
Company Detail Path
/organization/fresenius-kabi-deutschland-gmbh
Company Information
Pharmaceutical Company Name
Fresenius Kabi Deutschland Gmbh
Country Name
Sweden
Address
Utländsk Adr - Foreign Addr
Website
http://www.fresenius-kabi.com
Active Ingredients
PEMETREXED
25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 9, 2020
Approval ID
0f586833c8f8609e
Type
Standard
Back to CIMA-AEMPS Approvals